Biologicals

Papers
(The H4-Index of Biologicals is 11. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)
ArticleCitations
The regulatory landscape of biosimilars: WHO efforts and progress made from 2009 to 201934
Animal testing for vaccines. Implementing replacement, reduction and refinement: challenges and priorities28
Report of the second international conference on next generation sequencing for adventitious virus detection in biologics for humans and animals18
SARS-CoV-2: Virology, epidemiology, immunology and vaccine development17
Third human challenge trial conference, Oxford, United Kingdom, February 6–7, 2020, a meeting report16
Next-generation vaccines and the impacts of state-of-the-art in-silico technologies15
SARS-CoV-2 and the safety margins of cell-based biological medicinal products15
Novel application of adipose-derived mesenchymal stem cells via producing antiangiogenic factor TSP-1 in lung metastatic melanoma animal model14
Analytical and functional similarity of biosimilar ABP 798 with rituximab reference product14
Anti-CD20 monoclonal antibodies in Systemic Lupus Erythematosus13
SARS-CoV-2 controlled human infection models: Ethics, challenge agent production and regulatory issues12
Integrating 3Rs approaches in WHO guidelines for the batch release testing of biologicals11
0.39560198783875